Status:
RECRUITING
Remote Digital Care Effects in Adolescents With Type 1 Diabetes
Lead Sponsor:
University Hospital, Toulouse
Conditions:
type1diabetes
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative a...
Detailed Description
The use of digital technologies for the support and monitoring of diabetes have gradually become essential in recent years. The scientific literature reveals contrasting effects of digital and mobile ...
Eligibility Criteria
Inclusion
- Adolescent aged ≥12 and \<18, with primary type 1 diabetes detected for at least 12 months, treated with multi-injection insulin or insulin pump
- Glycated hemoglobin greater than or equal to 8% for more than 3 months
- Use a continuous interstitial glucose recording system (CGM)
- Have at least one parent/guardian with a significant caregiver role in the management of the adolescent's diabetes (as determined by the investigator) participating in the study
- Have digital media compatible with the digital applications of the TELEDUC- DIAB (Mobile phone and computer)
Exclusion
- • Other pathologies associated with diabetes which, according to the investigator, could interfere with glycemic control or the management of adolescent diabetes (examples: secondary diabetes, cystic fibrosis, Down syndrome; transplants, corticosteroid therapy, etc.)
Key Trial Info
Start Date :
April 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05421715
Start Date
April 11 2023
End Date
December 1 2024
Last Update
June 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital TOULOUSE
Toulouse, France, 31000